Pharmacovigilance

RISK Evaluation AND Mitigation Strategy

A Risk Evaluation and Mitigation Strategy (REMS) is an FDA-required safety program used when routine labeling alone is insufficient to manage serious risks.

Usage Examples

RISK Evaluation AND Mitigation Strategy guided escalation timing for expedited safety communication.
RISK Evaluation AND Mitigation Strategy was used in weekly safety governance meetings to prioritize risk actions.
The pharmacovigilance team documented RISK Evaluation AND Mitigation Strategy in aggregate benefit-risk evaluation updates.

What is RISK Evaluation AND Mitigation Strategy?

REMS programs can include Medication Guides, communication plans, and Elements to Assure Safe Use (ETASU). Teams must operationalize REMS requirements across prescribing, dispensing, monitoring, and compliance reporting workflows.

Regulatory Context

This term appears most often in pharmacovigilance workflows where submission quality, regulatory evidence, and audit readiness depend on consistent language. It is commonly referenced alongside FDA, ICH.

FDAEMAWHO

When This Matters

RISK Evaluation AND Mitigation Strategy guided escalation timing for expedited safety communication.
RISK Evaluation AND Mitigation Strategy was used in weekly safety governance meetings to prioritize risk actions.
The pharmacovigilance team documented RISK Evaluation AND Mitigation Strategy in aggregate benefit-risk evaluation updates.

Common Mistakes

Treating safety signal reviews as periodic instead of continuous.
Not linking new enforcement letters to internal CAPA and labeling workflows.
Using static templates for dynamic benefit-risk communication updates.

Related Regulations

FDAICH

Frequently Asked Questions

RISK Evaluation AND Mitigation Strategy is a regulatory concept used to improve submission quality, compliance consistency, and decision traceability.

RISK Evaluation AND Mitigation Strategy improves how teams detect, assess, and communicate emerging safety risks.

Weak execution of RISK Evaluation AND Mitigation Strategy often leads to avoidable deficiencies, rework, and slower authority review cycles.